 promin slow acetyl phenotyp patient sulfonamid hypersensit reaction delay hypersensit reaction sever advers effect sulfonamid current clinic use reaction differ metabol detoxif reactiv metabolit sulfonamid n-acetyl major metabol pathway sulfonamid slow acetyl phenotyp risk factor develop reaction acetyl phenotyp patient hypersensit reaction sulfonamid femal male group mean age year age rang year acetyl phenotyp ratio urinari caffein metabolit oral dose mg caffein nineteen patient slow acetyl incid slow acetyl race-match control popul slow acetyl phenotyp risk factor develop sulfonamid hypersensit reaction support role imbal pathway metabol detoxif sulfonamid pathogenesi reaction